Marinus Pharmaceuticals Depreciation & Amortization 2011-2026 | MRNS

Annual Depreciation & Amortization Marinus Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
500 K	300 K	300 K	300 K	200 K	100 K	126 K	23 K	11 K	5 K	10 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
500 K	5 K	170 K

Quarterly Depreciation & Amortization Marinus Pharmaceuticals

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	131 K	-	-	-	157 K	-	336 K	178 K	85 K	-	262 K	171 K	85 K	-	243 K	169 K	84 K	-	195 K	112 K	36 K	-	94 K	65 K	31 K	-	35 K	22 K	9 K	-	16 K	9 K	2 K	-	8 K	6 K	2 K	-	7 K	5 K	3 K	-	5.88 K	4.4 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
336 K	2 K	82.8 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Autolus Therapeutics plc AUTL	8.3 M	$ 1.35	-2.88 %	$ 359 M	Britain
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.57	-3.57 %	$ 16.1 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Coherus BioSciences CHRS	1.3 M	$ 1.61	-3.89 %	$ 189 M	USA
Akari Therapeutics, Plc AKTX	14 K	$ 3.52	-0.56 %	$ 237 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 314.88	-4.68 %	$ 41.3 B	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.91	2.52 %	$ 4.96 M	China
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Cerus Corporation CERS	1.43 M	$ 1.84	-0.81 %	$ 351 M	USA
AbbVie ABBV	762 M	$ 202.58	-1.96 %	$ 358 B	USA
Aquestive Therapeutics AQST	548 K	$ 4.03	-1.59 %	$ 431 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
AbCellera Biologics ABCL	18.4 M	$ 3.31	-2.36 %	$ 989 M	Canada
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 8.15	-0.85 %	$ 223 M	Israel